Xlife Sciences invests in Fuse-AI

Xlife Sciences invests in Fuse-AI

The Swiss company Xlife Sciences invests in the AI start-up Fuse-AI. Fuse-AI develops the ProstateCarcinoma.ai assistance system for the diagnosis of prostate cancer based on annotated MRI data using AI technology. 

Image: Xlife Sciences AG

The companies did not provide any details regarding the financial details of the agreement and the amount of the investment.

| News
Issue:
https://static1.squarespace.com/static/5b4f60a6ec4eb7a1fe598816/t/5d9367e023452849c28a68ee/1569941473380/Pressemitteilung_FUSE-AI.pdf

THIS MIGHT ALSO INTEREST YOU